SHEBA “ We have a plan laid out to 2030 to make sure that every process that can be automated , will be ”
EYAL ZIMLICHMAN CHIEF MEDICAL OFFICER , SHEBA MEDICAL CENTER
a direction towards the market needs , because we understand better than anyone what is needed , what the pain points are , and where the startups can come in and help us ."
A key industry partner is the pharmaceutical company Janssen . " We look for partners that share the same mindset as us , that are looking to transform healthcare as a strategy . The first industry partner that we signed was Janssen , and we learned very quickly that they matched us in terms of the audacity of where we want to be , that we ' re in it for the long run and these are not minor changes we want to create ."
Sheba ' s clinicians have been working with Janssen in various fields such as oncology and pulmonary hypertension , that Zimlichman says has the aim of transforming healthcare . " We want to move beyond the pill so it won ' t be just about the medication we ' re taking , but about building a whole digital solution around the condition . If the patient has diabetes , what would the digital environment be for that patient on top of the medication that he has to take ? That is our strategy at ARC , pharma together with digital health will create a much more comprehensive solution ."
Sheba ' s forward-thinking approach meant it played a leadership role in COVID- 19 efforts , not just in Israel but around the world . Towards the start of the pandemic ,
healthcareglobal . com 53